Treatment of hepatitis C virus/HIV coinfection

Clinics in Liver Disease

Volumn 9, Issue 3, 2005, Pages 525-533

  Chun, Sooyun ^a   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT; DIDANOSINE; ERYTHROPOIETIN; INTERFERON; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; STAVUDINE; ZIDOVUDINE;

ACUTE PANCREATITIS; ANEMIA; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FLU LIKE SYNDROME; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; IRRITABILITY; LACTIC ACIDOSIS; LYMPHOCYTOPENIA; METASTASIS; MITOCHONDRIAL TOXICITY; NEUTROPENIA; OUTCOMES RESEARCH; PANCREATITIS; REVIEW; SIDE EFFECT; SUICIDE; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON TYPE I, RECOMBINANT; RIBAVIRIN; TREATMENT REFUSAL;

EID: 22044441847     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2005.05.008     Document Type: Review

References (23)

1. M.J. Alter, D. Kruszon-Moran, and O.V. Nainan The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 351 1999 556 562
2. Centers for Disease Control and Prevention Hepatitis C virus and HIV coinfection Available at: www.cdc.gov/idu/hepatitis/hepc_andHIV_co Accessed January 14, 2005
3. K.E. Sherman, S.D. Rouster, and R.T. Chung Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group Clin Infect Dis 34 2002 831 837
4. C.L. Thio, K.R. Nolt, and J. Astemborski Screening for hepatitis C virus in human immunodeficiency virus-infected individuals J Clin Microbiol 38 2000 575 577
5. D.L. Thomas, J.M. Zenilman, and H.J. Alter Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships J Infect Dis 171 1995 768 775
6. M. Puoti, M. Bonacini, and A. Spinetti Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus J Infect Dis 183 2001 134 137
7. S. Pol, H. Fontaine, and F. Carnot Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients J Hepatol 29 1998 12 19
8. C.S. Graham, L.R. Baden, and E. Yu Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis Clin Infect Dis 33 2001 562 569
9. J. Garcia-Samaniego, M. Rodriguez, and J. Berenguer Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C Am J Gastroenterol 96 2001 179 183
10. B. Soto, A. Sanchez-Quijano, and L. Rodrigo Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis J Hepatol 26 1997 1 5
11. G. Greub, B. Ledergerber, and M. Battegay Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study Lancet 356 2000 1800 1805
12. M.S. Sulkowski, D.L. Thomas, and R.E. Chaisson Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection JAMA 283 2000 74 80
13. Y. Benhamou, V. Di Martino, and M. Bochet Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus coinfected patients: impact of protease inhibitor therapy Hepatology 34 2001 283 287
14. N. Qurishi, C. Kreuzberg, and G. Luchters Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
15. M.W. Fried, M.L. Shiffman, and K.R. Reddy Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
16. M. Manns, J.G. McHutchison, and S.C. Gordon Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial Lancet 358 2001 958 965
17. L. Moreno, C. Quereda, and A. Moreno Pegylated interferon alpha 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients AIDS 18 2004 67 73
18. M. Perez-Olmeda, M. Nunez, and M. Romero Pegylated IFN-alpha 2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients AIDS 17 2003 1023 1028
19. R.T. Chung, J. Andersen, and P. Volberding Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
20. F.J. Torriani, M. Rodriguez-Torres, and J.K. Rockstroh Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
21. F. Carrat, F. Bani-Sadr, and S. Pol Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2004 2839 2848
22. M. Laguno, J. Murillas, and J.L. Blanco Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients AIDS 18 2004 F27 F36
23. R. Fleisher, D. Boxwell, and K.E. Sherman Nucleoside analogues and mitochondrial toxicity Clin Infect Dis 38 2004 e79 e80